tifwp
-
Apr- 2023 -19 April
-
Dec- 2022 -30 December
-
Nov- 2022 -14 NovemberNews
NEW APPROVAL | PYRUKYND® Gets EU Green Light For Pyruvate Kinase (PK) Deficiency
The European Commission has granted, on November 10, 2022, marketing authorization to Agios Pharmaceuticals for PYRUKYND® intended for the…
Read More » -
7 November
-
Sep- 2022 -14 September
-
1 September
-
Aug- 2022 -30 August
-
29 August
-
Mar- 2022 -1 MarchScientific Literature
Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives
Chronic transfusion, used to manage clinically significant forms of thalassemia, carries complication risks including iron overload, alloimmunization, and allergic or…
Read More » -
Jan- 2022 -17 JanuaryScientific Literature
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management
Atrial fibrillation in patients with β-thalassemia has a higher incidence compared to the general population. Its pathophysiology is peculiar and…
Read More »
